These findings suggest that microglial function is impacted by Trem2 depletion, with specific genes becoming downregulated in response to AD-tau, while inflammatory signaling is altered primarily due to TREM2−/− deficiency. The gene discussed is MAPT; the disease is Alzheimer disease.